Failure to detect amphetamine or 1-amino-3-phenlypropane in humans or rats receiving the MAO inhibitor tranylcypromine
- 1 December 2000
- journal article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 61 (1-2) , 23-29
- https://doi.org/10.1016/s0165-0327(99)00188-3
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The GCMS analysis of tranylcypromine (Parnate) in a suspected overdoseForensic Science International, 1997
- The biotransformation of tranylcypromine by Cunninghamella echinulataCanadian Journal of Microbiology, 1991
- High Dose Tranylcypromine Therapy for Refractory DepressionPharmacopsychiatry, 1989
- Monoamine oxidase inhibitor withdrawal phenomena: symptoms and pathophysiologyActa Psychiatrica Scandinavica, 1988
- Detection and quantitation of a ring-hydroxylated metabolite of the antidepressant drug tranylcypromineJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1986
- A method for measurement of tranylcypromine in rat brain regions using gas chromatography with electron capture detectionBiochemical Pharmacology, 1981
- A procedure for extraction and separation of phenethylamine, tyramine and octopamineBiochemical Society Transactions, 1980
- Determination of tranylcypromine in human plasma and urine using high-resolution gas—liquid chromatography with nitrogen-sensitive detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1980
- Determination of Serum and Urine Concentrations of Tranylcypromine by Electron-Capture Gas-Liquid ChromatographyJournal of Analytical Toxicology, 1977
- Metabolism of Tranylcypromine-C14 and dl-Amphetamine-C14 in the RatJournal of Medicinal Chemistry, 1963